Largeaud, Laetitia <br/><br/>
Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors.  [electronic resource] 

 -  Leukemia research  06 2019 
 - 82-87 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-5835 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2019.04.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Isocitrate Dehydrogenase--genetics<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Middle Aged<br/>Mutation<br/>Neoplasm Recurrence, Local--drug therapy<br/>Prognosis<br/>Retrospective Studies<br/>Survival Rate